Laurie Weisberg bought $14k of SURG
director at SurgePays, Inc.. 7,809 shares at an average of $1.79, traded Nov 22, 2024, filed Nov 25, 2024.
Score components
- +15RoleDirector
- 0Trade size$14k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -9.0%, 3m -33.3%, 6m +52.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-24-047622, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 22, 2024 | POpen-market purchase Shares of Common Stock | +2,808 | $1.70 | $4,774 | 2,808 | Nov 25, 2024 |
| Nov 22, 2024 | POpen-market purchase Shares of Common Stock | +1 | $1.67 | $2 | 2,809 | Nov 25, 2024 |
| Nov 25, 2024 | POpen-market purchase Shares of Common Stock | +301 | $1.83 | $551 | 3,110 | Nov 25, 2024 |
| Nov 25, 2024 | POpen-market purchase Shares of Common Stock | +100 | $1.84 | $184 | 3,210 | Nov 25, 2024 |
| Nov 25, 2024 | POpen-market purchase Shares of Common Stock | +1,500 | $1.84 | $2,760 | 4,710 | Nov 25, 2024 |
| Nov 25, 2024 | POpen-market purchase Shares of Common Stock | +3,099 | $1.84 | $5,702 | 7,809 | Nov 25, 2024 |
Related signals
Other insiders at SurgePays, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | SURGbuy SurgePays, Inc. | David Allen May director | $21k 40,250 shares | +35% | |
| 36Weak | SURGbuy SurgePays, Inc. | David Allen May director | $62k 38,422 shares | +32% | |
| 37Weak | SURGsell SurgePays, Inc. | David Allen May director | $177k 63,000 shares | -34% | |
| 30Weak | SURGbuy SurgePays, Inc. | Kevin Brian Cox CEO and Chairman of Board | $41k 15,073 shares | +0% | |
| 21Weak | SurgePays, Inc. | Kevin Brian Cox CEO and Chairman of Board | $64k 35,180 shares | -1% | |
| 43Moderate | SurgePays, Inc. | Anthony George Evers Chief Financial Officer | $68k 36,666 shares | -15% | |
| 26Weak | SurgePays, Inc. | Richard Earl Schurfeld director | $5,593 3,500 shares | +8% | |
| 20Weak | SurgePays, Inc. | Kevin Brian Cox CEO and Chairman of Board | $51k 31,700 shares | -1% | |
| 42Moderate | SurgePays, Inc. | Anthony George Evers Chief Financial Officer | $59k 36,667 shares | -13% | |
| 20Weak | SurgePays, Inc. | Kevin Brian Cox CEO and Chairman of Board | $57k 32,375 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.